CN Stock MarketDetailed Quotes

600511 China National Medicines Corporation

Watchlist

29.47
-0.27-0.91%

Market Closed May 8 15:00 CST

22.24BMarket Cap11.12P/E (TTM)

China National Medicines Corporation Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

Assets

Current assets

Money funds

-4.82%8.85B

-0.36%10.89B

5.72%8.3B

10.28%8.62B

17.72%9.29B

22.81%10.93B

22.45%7.85B

15.46%7.81B

34.45%7.9B

21.79%8.9B

Notes receivable and accounts receivable

47.21%14.26B

37.33%12.34B

56.16%10.17B

53.84%9.87B

67.47%9.69B

55.40%8.99B

1.31%6.51B

8.90%6.41B

-1.38%5.79B

0.50%5.78B

-Notes receivable

----

-56.75%12.16M

-41.13%27.39M

16.42%27.66M

73.60%58.98M

-25.52%28.12M

118.67%46.53M

-31.92%23.76M

-17.95%33.98M

-11.08%37.76M

-Accounts receivable

48.11%14.26B

37.63%12.33B

56.86%10.14B

53.98%9.84B

67.44%9.63B

55.94%8.96B

0.92%6.47B

9.15%6.39B

-1.26%5.75B

0.59%5.75B

Other receivables (including interest and dividends)

6.33%346.62M

0.30%363.11M

-38.66%316.43M

-28.09%353.5M

3.28%326M

-7.10%362.03M

57.51%515.86M

327.25%491.59M

57.22%315.63M

40.91%389.69M

-Dividend receivable

----

0.00%562.81K

----

12.11%207.9M

43,954.58%206.62M

--562.81K

--5.11M

-Other receivable

----

24.05%353.5M

----

-5.87%362.03M

----

148.69%284.97M

----

39.06%384.59M

Contractual assets

--5.04M

--5.41M

----

Advance payment

206.57%376.4M

40.70%198.49M

305.86%280.07M

45.26%136.96M

-6.11%122.78M

-28.00%141.07M

-37.34%69.01M

-16.61%94.28M

-25.11%130.77M

289.76%195.92M

Inventories

17.10%5.04B

25.10%4.96B

22.28%5.26B

25.73%4.96B

6.85%4.31B

6.56%3.96B

11.18%4.3B

6.47%3.95B

-0.75%4.03B

5.76%3.72B

Receivable financing

-68.01%1.54B

-59.35%1.58B

-35.39%5.44B

-36.23%5.24B

-38.51%4.8B

-42.47%3.89B

-4.48%8.42B

14.55%8.22B

-2.49%7.81B

-11.40%6.77B

Other current assets

122.71%25.52M

166.27%23.14M

57.79%8.33M

23.49%10.17M

-85.40%11.46M

-40.16%8.69M

-25.53%5.28M

-81.81%8.24M

-40.14%78.46M

-56.93%14.52M

Total current assets

6.62%30.44B

7.35%30.36B

7.59%29.77B

8.15%29.18B

9.63%28.55B

9.76%28.28B

6.57%27.67B

13.34%26.98B

7.12%26.04B

4.80%25.76B

Non Current assets

Other equity investment

9.05%37.07M

-11.04%37.18M

-1.95%35.87M

-16.05%30.43M

-17.11%33.99M

17.51%41.8M

8.98%36.58M

-10.69%36.25M

11.79%41.01M

-3.73%35.57M

Other non-current financial assets

-19.48%101.48M

-24.38%104.41M

-24.30%122.61M

-22.20%126.03M

-2.99%126.03M

5.82%138.07M

24.14%161.98M

52.12%161.98M

22.00%129.91M

22.54%130.48M

Investment real estate

-6.67%16.09M

-6.56%16.38M

6,371.04%16.66M

6,246.71%16.95M

6,130.99%17.24M

6,023.00%17.53M

-12.94%257.51K

-12.54%267.09K

-12.16%276.66K

-11.80%286.23K

Long-term equity investment

16.76%2.17B

17.77%2.03B

16.30%1.87B

18.93%1.77B

18.02%1.86B

18.58%1.73B

18.81%1.61B

4.08%1.49B

19.36%1.57B

19.23%1.46B

Fixed assets

----

-1.59%531.9M

----

-2.18%551.82M

----

7.28%540.52M

----

6.99%564.12M

Constru in process

----

-97.68%836.02K

----

-92.99%2.54M

----

-52.89%36.07M

----

-36.57%36.21M

Intangible assets

0.87%263.27M

7.22%276.76M

5.73%260.2M

5.93%264.66M

2.89%260.99M

-1.83%258.11M

-8.46%246.09M

-8.49%249.84M

1.33%253.65M

1.65%262.92M

Development expenditure

-3.99%115.16M

-10.30%114.8M

38.40%134.67M

39.96%128.59M

63.75%119.95M

88.23%127.99M

56.06%97.3M

72.15%91.87M

6.22%73.25M

0.65%67.99M

Goodwill

0.00%203.77M

Long deferred expense

52.56%38.11M

70.25%37.58M

45.83%29.07M

56.21%27.53M

43.91%24.98M

21.33%22.08M

3.08%19.93M

-11.31%17.62M

-15.34%17.36M

-17.48%18.19M

Deferred tax assets

21.74%154.99M

20.34%149.07M

15.63%142.21M

21.69%137.99M

3.44%127.31M

-0.40%123.87M

5.91%122.99M

-4.43%113.39M

9.84%123.07M

7.27%124.37M

Usufruct assets

-11.80%323.1M

27.07%346.48M

88.44%374.66M

68.04%374.48M

54.88%366.34M

5.86%272.67M

-33.11%198.82M

-18.30%222.86M

-4.83%236.52M

-1.20%257.57M

Other non current assets

3.51%715.5M

4.73%718.47M

21.41%850.47M

9.16%755.56M

0.32%691.24M

-0.09%686.05M

154.25%700.51M

360.43%692.13M

370.17%689.01M

25.36%686.67M

Total non current assets

6.55%4.65B

9.53%4.57B

15.24%4.57B

13.33%4.37B

11.17%4.37B

8.55%4.17B

18.09%3.96B

18.63%3.86B

27.27%3.93B

12.21%3.84B

Total assets

6.61%35.1B

7.63%34.93B

8.55%34.34B

8.80%33.55B

9.83%32.92B

9.61%32.45B

7.89%31.63B

13.97%30.84B

9.39%29.97B

5.71%29.61B

Liabilities

Current liabilities

Short term loan

184.90%523.55M

80.75%485.06M

27.61%284.32M

10.82%239.71M

-27.33%183.76M

6.46%268.35M

-26.04%222.81M

-28.04%216.32M

67.32%252.86M

-41.22%252.06M

Notes payable and accounts payable

12.14%11.89B

10.45%12.09B

9.59%12.52B

6.55%11.92B

7.38%10.6B

10.35%10.94B

5.47%11.42B

18.69%11.19B

-1.26%9.88B

-1.40%9.92B

-Notes payable

38.45%2.88B

34.20%3.5B

36.47%2.62B

51.47%2.63B

14.11%2.08B

2.57%2.61B

16.34%1.92B

8.51%1.74B

10.55%1.82B

45.33%2.54B

-Accounts payable

5.73%9.02B

3.00%8.58B

4.17%9.9B

-1.69%9.29B

5.86%8.53B

13.04%8.33B

3.51%9.5B

20.77%9.45B

-3.59%8.05B

-11.26%7.37B

Contract liabilities

126.34%268.32M

350.34%275.25M

40.52%107.65M

29.85%105.95M

50.75%118.55M

-65.45%61.12M

16.12%76.61M

28.28%81.6M

-6.24%78.64M

305.02%176.9M

Salaries payable

13.17%107.34M

-0.37%169.56M

3.77%87.79M

-3.26%85.47M

-1.85%94.85M

6.28%170.19M

-0.54%84.6M

0.20%88.35M

6.37%96.64M

-5.33%160.14M

Taxs payable

10.77%146.33M

11.57%236.52M

-43.52%130.4M

-41.88%88.47M

18.39%132.1M

-9.93%212M

6.35%230.88M

76.93%152.22M

27.43%111.58M

12.08%235.38M

Other payable (including interest and dividends)

-39.32%1.53B

-30.72%1.5B

-20.64%1.4B

5.64%1.82B

15.77%2.52B

12.91%2.16B

-2.44%1.77B

-2.74%1.72B

30.23%2.17B

10.07%1.92B

-Interest payable

----

-65.28%15.35M

-36.02%28.04M

8.17%47.3M

16.45%69.06M

15.29%44.22M

-4.82%43.83M

-9.39%43.73M

13.36%59.31M

-Dividend payable

--3.33M

-88.13%3.33M

----

23.34%28.04M

36.84%31.11M

-91.89%1.7M

----

236.71%22.73M

-Other payable

----

6.83%1.79B

----

12.67%2.07B

-3.34%1.69B

-1.59%1.68B

----

9.06%1.83B

Non current liabilities due within one year

2.88%82.02M

35.27%100.2M

20.71%87.94M

16.69%96.34M

-5.77%79.72M

-7.98%74.08M

-19.73%72.85M

-3.73%82.56M

9.96%84.61M

-7.70%80.5M

Other current liabilities

7.78%2.69M

185.71%3.44M

-54.80%1.19M

-19.21%1.65M

-13.62%2.49M

18.01%1.2M

114.21%2.64M

71.85%2.04M

83.53%2.89M

60.51%1.02M

Total current liabilities

5.95%14.55B

6.92%14.86B

5.33%14.62B

6.09%14.36B

8.33%13.73B

9.07%13.89B

3.56%13.88B

14.47%13.54B

4.23%12.68B

0.01%12.74B

Current liabilities

Long term salaries pay

-38.41%271K

-24.05%341K

-2.00%440K

-16.70%449K

Deferred tax liabilities

-17.05%23.14M

-9.67%24.19M

-0.12%29.56M

-8.82%27.54M

-13.31%27.9M

-20.00%26.78M

-9.89%29.59M

-8.91%30.2M

-5.89%32.19M

-5.42%33.47M

Long term deferred income

-14.92%37.66M

-15.77%38.79M

-1.19%40.64M

-1.66%42.42M

-2.08%44.27M

-0.64%46.06M

-3.85%41.13M

-1.10%43.14M

4.84%45.21M

8.66%46.35M

Lease liabilities

-10.57%252.35M

27.12%260.69M

120.71%292.34M

85.48%281.17M

79.14%282.17M

12.33%205.08M

-35.51%132.45M

-22.49%151.6M

-12.75%157.52M

-7.46%182.57M

Other non current liabilities

-4.55%773.55M

3.54%773.55M

20.37%899.32M

8.48%810.46M

0.00%747.14M

131.66%747.14M

225.99%747.14M

247.20%747.14M

16.78%747.14M

Total non current liabilities

-6.72%1.09B

7.02%1.1B

32.76%1.26B

28.61%1.25B

18.60%1.17B

1.54%1.03B

57.39%950.76M

93.69%972.52M

107.46%982.5M

10.30%1.01B

Total liabilities

4.96%15.64B

6.93%15.95B

7.09%15.88B

7.60%15.61B

9.07%14.9B

8.51%14.92B

5.88%14.83B

17.70%14.51B

8.09%13.66B

0.70%13.75B

Shareholders equity

Paid-in capital

0.00%754.5M

Capital reserve funds

0.00%2.35B

-0.00%2.35B

0.00%2.35B

Surplus reserve funds

0.00%607.3M

0.01%607.3M

-0.03%607.3M

-0.04%607.24M

-0.00%607.46M

Retained profit

10.85%13.85B

11.27%13.39B

13.40%12.87B

13.96%12.39B

14.68%12.49B

14.83%12.03B

14.10%11.35B

15.93%10.87B

15.68%10.89B

15.87%10.48B

Other composite income

9.27%27.19M

-11.26%27.28M

-1.99%26.29M

-16.41%22.21M

-11.51%24.89M

27.85%30.74M

19.89%26.83M

-3.85%26.57M

13.80%28.12M

-3.48%24.04M

Shareholders equity without minority interests

8.37%17.59B

8.57%17.13B

10.08%16.61B

10.36%16.12B

10.91%16.23B

10.98%15.78B

10.28%15.09B

11.38%14.61B

11.25%14.63B

11.23%14.21B

Minority interests

4.54%1.87B

5.10%1.85B

7.72%1.85B

5.66%1.82B

6.61%1.79B

6.85%1.76B

5.09%1.72B

6.54%1.72B

4.31%1.68B

4.39%1.64B

Total shareholder equity

7.98%19.46B

8.22%18.98B

9.84%18.46B

9.87%17.94B

10.46%18.02B

10.55%17.53B

9.73%16.8B

10.85%16.33B

10.49%16.31B

10.48%15.86B

Total liabilityies and equity

6.61%35.1B

7.63%34.93B

8.55%34.34B

8.80%33.55B

9.83%32.92B

9.61%32.45B

7.89%31.63B

13.97%30.84B

9.39%29.97B

5.71%29.61B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

Ernst & Young Huaming Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022
Assets
Current assets
Money funds	-4.82%8.85B	-0.36%10.89B	5.72%8.3B	10.28%8.62B	17.72%9.29B	22.81%10.93B	22.45%7.85B	15.46%7.81B	34.45%7.9B	21.79%8.9B
Notes receivable and accounts receivable	47.21%14.26B	37.33%12.34B	56.16%10.17B	53.84%9.87B	67.47%9.69B	55.40%8.99B	1.31%6.51B	8.90%6.41B	-1.38%5.79B	0.50%5.78B
-Notes receivable	----	-56.75%12.16M	-41.13%27.39M	16.42%27.66M	73.60%58.98M	-25.52%28.12M	118.67%46.53M	-31.92%23.76M	-17.95%33.98M	-11.08%37.76M
-Accounts receivable	48.11%14.26B	37.63%12.33B	56.86%10.14B	53.98%9.84B	67.44%9.63B	55.94%8.96B	0.92%6.47B	9.15%6.39B	-1.26%5.75B	0.59%5.75B
Other receivables (including interest and dividends)	6.33%346.62M	0.30%363.11M	-38.66%316.43M	-28.09%353.5M	3.28%326M	-7.10%362.03M	57.51%515.86M	327.25%491.59M	57.22%315.63M	40.91%389.69M
-Dividend receivable	----	----	----	----	0.00%562.81K	----	12.11%207.9M	43,954.58%206.62M	--562.81K	--5.11M
-Other receivable	----	----	----	24.05%353.5M	----	-5.87%362.03M	----	148.69%284.97M	----	39.06%384.59M
Contractual assets	--5.04M	--5.41M	----	----	----	----	----	----	----	----
Advance payment	206.57%376.4M	40.70%198.49M	305.86%280.07M	45.26%136.96M	-6.11%122.78M	-28.00%141.07M	-37.34%69.01M	-16.61%94.28M	-25.11%130.77M	289.76%195.92M
Inventories	17.10%5.04B	25.10%4.96B	22.28%5.26B	25.73%4.96B	6.85%4.31B	6.56%3.96B	11.18%4.3B	6.47%3.95B	-0.75%4.03B	5.76%3.72B
Receivable financing	-68.01%1.54B	-59.35%1.58B	-35.39%5.44B	-36.23%5.24B	-38.51%4.8B	-42.47%3.89B	-4.48%8.42B	14.55%8.22B	-2.49%7.81B	-11.40%6.77B
Other current assets	122.71%25.52M	166.27%23.14M	57.79%8.33M	23.49%10.17M	-85.40%11.46M	-40.16%8.69M	-25.53%5.28M	-81.81%8.24M	-40.14%78.46M	-56.93%14.52M
Total current assets	6.62%30.44B	7.35%30.36B	7.59%29.77B	8.15%29.18B	9.63%28.55B	9.76%28.28B	6.57%27.67B	13.34%26.98B	7.12%26.04B	4.80%25.76B
Non Current assets
Other equity investment	9.05%37.07M	-11.04%37.18M	-1.95%35.87M	-16.05%30.43M	-17.11%33.99M	17.51%41.8M	8.98%36.58M	-10.69%36.25M	11.79%41.01M	-3.73%35.57M
Other non-current financial assets	-19.48%101.48M	-24.38%104.41M	-24.30%122.61M	-22.20%126.03M	-2.99%126.03M	5.82%138.07M	24.14%161.98M	52.12%161.98M	22.00%129.91M	22.54%130.48M
Investment real estate	-6.67%16.09M	-6.56%16.38M	6,371.04%16.66M	6,246.71%16.95M	6,130.99%17.24M	6,023.00%17.53M	-12.94%257.51K	-12.54%267.09K	-12.16%276.66K	-11.80%286.23K
Long-term equity investment	16.76%2.17B	17.77%2.03B	16.30%1.87B	18.93%1.77B	18.02%1.86B	18.58%1.73B	18.81%1.61B	4.08%1.49B	19.36%1.57B	19.23%1.46B
Fixed assets	----	----	----	-1.59%531.9M	----	-2.18%551.82M	----	7.28%540.52M	----	6.99%564.12M
Constru in process	----	----	----	-97.68%836.02K	----	-92.99%2.54M	----	-52.89%36.07M	----	-36.57%36.21M
Intangible assets	0.87%263.27M	7.22%276.76M	5.73%260.2M	5.93%264.66M	2.89%260.99M	-1.83%258.11M	-8.46%246.09M	-8.49%249.84M	1.33%253.65M	1.65%262.92M
Development expenditure	-3.99%115.16M	-10.30%114.8M	38.40%134.67M	39.96%128.59M	63.75%119.95M	88.23%127.99M	56.06%97.3M	72.15%91.87M	6.22%73.25M	0.65%67.99M
Goodwill	0.00%203.77M	0.00%203.77M	0.00%203.77M	0.00%203.77M	0.00%203.77M	0.00%203.77M	0.00%203.77M	0.00%203.77M	0.00%203.77M	0.00%203.77M
Long deferred expense	52.56%38.11M	70.25%37.58M	45.83%29.07M	56.21%27.53M	43.91%24.98M	21.33%22.08M	3.08%19.93M	-11.31%17.62M	-15.34%17.36M	-17.48%18.19M
Deferred tax assets	21.74%154.99M	20.34%149.07M	15.63%142.21M	21.69%137.99M	3.44%127.31M	-0.40%123.87M	5.91%122.99M	-4.43%113.39M	9.84%123.07M	7.27%124.37M
Usufruct assets	-11.80%323.1M	27.07%346.48M	88.44%374.66M	68.04%374.48M	54.88%366.34M	5.86%272.67M	-33.11%198.82M	-18.30%222.86M	-4.83%236.52M	-1.20%257.57M
Other non current assets	3.51%715.5M	4.73%718.47M	21.41%850.47M	9.16%755.56M	0.32%691.24M	-0.09%686.05M	154.25%700.51M	360.43%692.13M	370.17%689.01M	25.36%686.67M
Total non current assets	6.55%4.65B	9.53%4.57B	15.24%4.57B	13.33%4.37B	11.17%4.37B	8.55%4.17B	18.09%3.96B	18.63%3.86B	27.27%3.93B	12.21%3.84B
Total assets	6.61%35.1B	7.63%34.93B	8.55%34.34B	8.80%33.55B	9.83%32.92B	9.61%32.45B	7.89%31.63B	13.97%30.84B	9.39%29.97B	5.71%29.61B
Liabilities
Current liabilities
Short term loan	184.90%523.55M	80.75%485.06M	27.61%284.32M	10.82%239.71M	-27.33%183.76M	6.46%268.35M	-26.04%222.81M	-28.04%216.32M	67.32%252.86M	-41.22%252.06M
Notes payable and accounts payable	12.14%11.89B	10.45%12.09B	9.59%12.52B	6.55%11.92B	7.38%10.6B	10.35%10.94B	5.47%11.42B	18.69%11.19B	-1.26%9.88B	-1.40%9.92B
-Notes payable	38.45%2.88B	34.20%3.5B	36.47%2.62B	51.47%2.63B	14.11%2.08B	2.57%2.61B	16.34%1.92B	8.51%1.74B	10.55%1.82B	45.33%2.54B
-Accounts payable	5.73%9.02B	3.00%8.58B	4.17%9.9B	-1.69%9.29B	5.86%8.53B	13.04%8.33B	3.51%9.5B	20.77%9.45B	-3.59%8.05B	-11.26%7.37B
Contract liabilities	126.34%268.32M	350.34%275.25M	40.52%107.65M	29.85%105.95M	50.75%118.55M	-65.45%61.12M	16.12%76.61M	28.28%81.6M	-6.24%78.64M	305.02%176.9M
Salaries payable	13.17%107.34M	-0.37%169.56M	3.77%87.79M	-3.26%85.47M	-1.85%94.85M	6.28%170.19M	-0.54%84.6M	0.20%88.35M	6.37%96.64M	-5.33%160.14M
Taxs payable	10.77%146.33M	11.57%236.52M	-43.52%130.4M	-41.88%88.47M	18.39%132.1M	-9.93%212M	6.35%230.88M	76.93%152.22M	27.43%111.58M	12.08%235.38M
Other payable (including interest and dividends)	-39.32%1.53B	-30.72%1.5B	-20.64%1.4B	5.64%1.82B	15.77%2.52B	12.91%2.16B	-2.44%1.77B	-2.74%1.72B	30.23%2.17B	10.07%1.92B
-Interest payable	----	----	-65.28%15.35M	-36.02%28.04M	8.17%47.3M	16.45%69.06M	15.29%44.22M	-4.82%43.83M	-9.39%43.73M	13.36%59.31M
-Dividend payable	--3.33M	-88.13%3.33M	----	----	----	23.34%28.04M	36.84%31.11M	-91.89%1.7M	----	236.71%22.73M
-Other payable	----	----	----	6.83%1.79B	----	12.67%2.07B	-3.34%1.69B	-1.59%1.68B	----	9.06%1.83B
Non current liabilities due within one year	2.88%82.02M	35.27%100.2M	20.71%87.94M	16.69%96.34M	-5.77%79.72M	-7.98%74.08M	-19.73%72.85M	-3.73%82.56M	9.96%84.61M	-7.70%80.5M
Other current liabilities	7.78%2.69M	185.71%3.44M	-54.80%1.19M	-19.21%1.65M	-13.62%2.49M	18.01%1.2M	114.21%2.64M	71.85%2.04M	83.53%2.89M	60.51%1.02M
Total current liabilities	5.95%14.55B	6.92%14.86B	5.33%14.62B	6.09%14.36B	8.33%13.73B	9.07%13.89B	3.56%13.88B	14.47%13.54B	4.23%12.68B	0.01%12.74B
Current liabilities
Long term salaries pay	-38.41%271K	-38.41%271K	-24.05%341K	-24.05%341K	-2.00%440K	-2.00%440K	-16.70%449K	-16.70%449K	-16.70%449K	-16.70%449K
Deferred tax liabilities	-17.05%23.14M	-9.67%24.19M	-0.12%29.56M	-8.82%27.54M	-13.31%27.9M	-20.00%26.78M	-9.89%29.59M	-8.91%30.2M	-5.89%32.19M	-5.42%33.47M
Long term deferred income	-14.92%37.66M	-15.77%38.79M	-1.19%40.64M	-1.66%42.42M	-2.08%44.27M	-0.64%46.06M	-3.85%41.13M	-1.10%43.14M	4.84%45.21M	8.66%46.35M
Lease liabilities	-10.57%252.35M	27.12%260.69M	120.71%292.34M	85.48%281.17M	79.14%282.17M	12.33%205.08M	-35.51%132.45M	-22.49%151.6M	-12.75%157.52M	-7.46%182.57M
Other non current liabilities	-4.55%773.55M	3.54%773.55M	20.37%899.32M	20.37%899.32M	8.48%810.46M	0.00%747.14M	131.66%747.14M	225.99%747.14M	247.20%747.14M	16.78%747.14M
Total non current liabilities	-6.72%1.09B	7.02%1.1B	32.76%1.26B	28.61%1.25B	18.60%1.17B	1.54%1.03B	57.39%950.76M	93.69%972.52M	107.46%982.5M	10.30%1.01B
Total liabilities	4.96%15.64B	6.93%15.95B	7.09%15.88B	7.60%15.61B	9.07%14.9B	8.51%14.92B	5.88%14.83B	17.70%14.51B	8.09%13.66B	0.70%13.75B
Shareholders equity
Paid-in capital	0.00%754.5M	0.00%754.5M	0.00%754.5M	0.00%754.5M	0.00%754.5M	0.00%754.5M	0.00%754.5M	0.00%754.5M	0.00%754.5M	0.00%754.5M
Capital reserve funds	0.00%2.35B	-0.00%2.35B	-0.00%2.35B	-0.00%2.35B	-0.00%2.35B	0.00%2.35B	0.00%2.35B	0.00%2.35B	0.00%2.35B	0.00%2.35B
Surplus reserve funds	0.00%607.3M	0.00%607.3M	0.01%607.3M	0.01%607.3M	-0.03%607.3M	-0.03%607.3M	-0.04%607.24M	-0.04%607.24M	-0.00%607.46M	-0.00%607.46M
Retained profit	10.85%13.85B	11.27%13.39B	13.40%12.87B	13.96%12.39B	14.68%12.49B	14.83%12.03B	14.10%11.35B	15.93%10.87B	15.68%10.89B	15.87%10.48B
Other composite income	9.27%27.19M	-11.26%27.28M	-1.99%26.29M	-16.41%22.21M	-11.51%24.89M	27.85%30.74M	19.89%26.83M	-3.85%26.57M	13.80%28.12M	-3.48%24.04M
Shareholders equity without minority interests	8.37%17.59B	8.57%17.13B	10.08%16.61B	10.36%16.12B	10.91%16.23B	10.98%15.78B	10.28%15.09B	11.38%14.61B	11.25%14.63B	11.23%14.21B
Minority interests	4.54%1.87B	5.10%1.85B	7.72%1.85B	5.66%1.82B	6.61%1.79B	6.85%1.76B	5.09%1.72B	6.54%1.72B	4.31%1.68B	4.39%1.64B
Total shareholder equity	7.98%19.46B	8.22%18.98B	9.84%18.46B	9.87%17.94B	10.46%18.02B	10.55%17.53B	9.73%16.8B	10.85%16.33B	10.49%16.31B	10.48%15.86B
Total liabilityies and equity	6.61%35.1B	7.63%34.93B	8.55%34.34B	8.80%33.55B	9.83%32.92B	9.61%32.45B	7.89%31.63B	13.97%30.84B	9.39%29.97B	5.71%29.61B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)	--	--	--	Ernst & Young Huaming Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

600511 China National Medicines Corporation

China National Medicines Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights

Discussing

Latest News

Investment Course